Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Bryan Williams, A Stanley, Richard Hobbs et al.|The Lancet Diabetes & Endocrinology|2018

Cited by 340